Staphylococcus aureus carriage in adult peritoneal dialysis patients and their spouses

Peritoneal Dialysis International

Volumn 17, Issue 5, 1997, Pages 480-485

  Bistrup, Claus ^a,b   Jensen, Kjeld Truberg ^a   Kabel, Bodil ^a   Pedersen, Robert Smith ^a  

^a ESBJERG HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

Peritonitis; Phage type; Spouse; Staph. aureus carriage

Indexed keywords

ADULT; ARTICLE; BACTERIAL PERITONITIS; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE CARRIER; FEMALE; HUMAN; INCIDENCE; MALE; NOSE SMEAR; PRIORITY JOURNAL; SPOUSE; STAPHYLOCOCCUS AUREUS;

EID: 0030666528     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700511     Document Type: Article

References (23)

1. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int 1993; 43(Suppl 40):S4-15.
2. Maiorca R, Vonesh EF, Cavalli PL, et al. A multicenter, selection-adjusted comparison of patients and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11:118-27.
3. Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B. An analysis of ten-years trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1991; 31:29-34.
4. Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 1993; 13(Suppl 2): S332-4.
5. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC. Staphylococcus aureus nasal carriage, exit-site infection, and catheter loss in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1989; 9:61-4.
6. Poole-Warren LA, Hallett MD, Hone PW, Burden SH, Farrell PC. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial. Clin Nephrol 1991; 35: 198-206.
7. Wanten GJA, van Oost P, Schneeberger PM, Koolen MI. Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study. Perit Dial Int 1996; 16:352-6.
8. Oxton LL, Zimmerman SW, Roecker EB, Wakeen M. Risk factors for peritoneal dialysis-related infections. Perit Dial Int 1994; 14:137-14.
9. Swartz R, Messana J, Starmann B, Weber M, Reynolds J. Preventing Staphylococcus aureus infections during chronic peritoneal dialysis. J Am Soc Nephrol 1991; 2:1085-91.
10. Ludlam HA, Young AE, Berry AJ, Phillips I. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis. J Hosp Infect 1989; 14:293-301.
11. Simpson AJH, Anderson JR, Farfan GA. Family infection with methicillin-resistant Staphylococcus aureus. Lancet 1995; 346:914.
12. Zimakoff J, Rosdahl VT, Petersen W, Scheibel J. Recurrent staphylococcal furunculosis in families. Scand J Infect Dis 1988; 20:403-5.
13. Brahm M. A simple diagnostic method of peritonitis in patients on CAPD. Scand J Urol Nephrol 1984; 18:223-5.
14. Vas SI. Peritonitis. In: Nolph KD. editor. Peritoneal dialysis. Dordrecht: Kluwer Academic, 1989:261-88.
15. Pérez-Fontán M, García-Falcón T, Rosales M, et al. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. Am J Kidney Dis 1993; 22:708-12.
16. Zimmerman SW, Ahrens E, Johnson CA, et al. Randomized controlled trial of prophylactic rifampicin for peritoneal dialysis-related infections. Am J Kidney Dis 1991; 18:225-31.
17. Sesso R, Parisio K, Dalboni A, et al. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.Clin Nephrol 1994;41:370-6.
18. Eriksen NHR, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 1995; 115:51-60.
19. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 1986; 315:91-6.
20. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322:505-9.
21. Pignatari A, Phaller M, Hollis R, Sesso R, Leme I, Herwaldt L. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 1990; 28:1898-902.
22. Hudson IRB. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 1994; 24:81-98.
23. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic rifampicin. Am J Kidney Dis 1996; 27:695-700.